ABSI

Absci Corp

Oct 13 • 02:46PM ET

3.70

+0.02 0.54 %

Healthcare • Biotechnology • USA • NASD

Peers: INCY VRTX REGN BMRN SRPT EXEL NBIX IONS ALNY CRSP

| Held by: ARKG IWM VTI IWO IBB VXF SCHA VTWO IWC IWN

Index	RUT	P/E	-	EPS (ttm)	-0.95	Insider Own	12.73%	Shs Outstand	149.52M	Perf Week	-1.60%
Market Cap	553.23M	Forward P/E	-	EPS next Y	-0.67	Insider Trans	0.83%	Shs Float	130.49M	Perf Month	45.10%
Enterprise Value	426.97M	PEG	-	EPS next Q	-0.20	Inst Own	60.00%	Short Float	25.32%	Perf Quarter	43.97%
Income	-113.30M	P/S	133.63	EPS this Y	7.45%	Inst Trans	3.10%	Short Ratio	5.84	Perf Half Y	22.52%
Sales	4.14M	P/B	2.72	EPS next Y	22.48%	ROA	-48.69%	Short Interest	33.04M	Perf YTD	41.22%
Book/sh	1.36	P/C	4.14	EPS next 5Y	6.35%	ROE	-57.39%	52W High	6.33 -41.55%	Perf Year	-2.89%
Cash/sh	0.89	P/FCF	-	EPS past 3/5Y	5.67% -29.30%	ROIC	-63.98%	52W Low	2.01 84.08%	Perf 3Y	17.09%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-1.76% 17.09%	Gross Margin	-205.97%	Volatility	11.25% 8.55%	Perf 5Y	-
Dividend TTM	-	EV/Sales	103.13	EPS Y/Y TTM	-1.34%	Oper. Margin	-2846.57%	ATR (14)	0.28	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.39	Sales Y/Y TTM	27.32%	Profit Margin	-2737.94%	RSI (14)	62.10	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.39	EPS Q/Q	-9.31%	SMA20	17.74%	Beta	2.00	Target Price	8.13
Payout	-	Debt/Eq	0.04	Sales Q/Q	-53.31%	SMA50	29.41%	Rel Volume	1.18	Prev Close	3.68
Employees	157	LT Debt/Eq	0.02	Earnings	Aug 12 AMC	SMA200	19.60%	Avg Volume	5.66M	Price	3.70
IPO	Jul 22, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-15.05% -52.83%	Trades		Volume	5,487,134	Change	0.54%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-02-25	Initiated	JP Morgan	Overweight
Jul-03-25	Resumed	Morgan Stanley	Overweight	$7
Jan-22-25	Initiated	Needham	Buy	$9
Oct-02-24	Initiated	Guggenheim	Buy	$10
Jul-03-24	Initiated	Morgan Stanley	Overweight	$7
Mar-14-24	Initiated	Scotiabank	Sector Outperform	$13
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight	$3
May-04-23	Initiated	H.C. Wainwright	Buy	$4
Aug-12-22	Downgrade	JP Morgan	Overweight → Underweight
Jul-18-22	Initiated	Truist	Buy	$8
Mar-02-22	Resumed	Cowen	Market Perform
Feb-01-22	Initiated	Berenberg	Buy	$28
Nov-10-21	Downgrade	BofA Securities	Neutral → Underperform	$10
Oct-15-21	Resumed	Cowen	Market Perform
Aug-16-21	Initiated	Stifel	Hold	$28
Aug-16-21	Initiated	Credit Suisse	Outperform	$40
Aug-16-21	Initiated	Cowen	Market Perform
Aug-16-21	Initiated	BofA Securities	Neutral	$26

Show Previous Ratings

Today 12:12PM	2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk (MarketBeat)
Sep-21-25 09:26AM	Absci Corporation (ABSI) Secures $64M Financing to Drive AI Drug Discovery Through 2028 (Insider Monkey)
Sep-11-25 08:00AM	Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD (GlobeNewswire) +15.13%
Aug-25-25 04:05PM	Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg (GlobeNewswire)
Aug-20-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
03:12AM	Loading…
Aug-13-25 03:12AM	Absci Corp (ABSI) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges (GuruFocus.com) +5.05%
Aug-12-25 05:20PM	Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results (GlobeNewswire)
Aug-11-25 09:31AM	Absci Corp (ABSI) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Aug-07-25 10:00AM	SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
02:00AM	Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target (GlobeNewswire)
Aug-06-25 10:00AM	Absci Corporation (ABSI) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Aug-05-25 05:15PM	Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates (Zacks)
Aug-04-25 05:15PM	Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Jul-30-25 04:05PM	Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025 (GlobeNewswire)
09:56AM	Loading…
Jul-25-25 09:56AM	Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains? (Zacks) -17.66%
Jul-24-25 08:45PM	Absci Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:54PM	Absci Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jul-11-25 07:15PM	Morgan Stanley Assumes Coverage on Absci Corporation (ABSI) with $7 Target (Insider Monkey)
Jul-07-25 08:30AM	iRhythm Technologies Announces Board Member Retirements and New Director Appointments (GlobeNewswire) -6.86%
08:00AM	Absci Appoints Biopharma Leader Mary Szela to Board of Directors (GlobeNewswire)
May-20-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-14-25 08:32AM	Q1 2025 Absci Corp Earnings Call (Thomson Reuters StreetEvents)
03:17AM	Absci Corp (ABSI) Q1 2025 Earnings Call Highlights: Transition to Clinical Stage and Strong ... (GuruFocus.com)
May-13-25 05:30PM	Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results (GlobeNewswire)
04:01PM	Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease (GlobeNewswire)
May-12-25 09:35AM	What To Expect From Absci Corp (ABSI) Q1 2025 Earnings (GuruFocus.com) +6.55%
Apr-14-25 04:05PM	Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025 (GlobeNewswire)
11:40AM	Absci: FDA Announcement Provides Only A Modest Tailwind (Seeking Alpha)
03:15PM	Loading…
Apr-03-25 03:15PM	Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market (Seeking Alpha) -9.88%
Mar-31-25 07:15AM	Which Healthcare Stock Is the Best Buy Right Now? (MarketBeat) -7.04%
Mar-26-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire) -5.54%
Mar-21-25 10:57PM	Absci Corp (ABSI) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Mar-19-25 09:08AM	Q4 2024 Absci Corp Earnings Call (Thomson Reuters StreetEvents)
03:03AM	Absci Corp (ABSI) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ... (GuruFocus.com)
Mar-18-25 04:05PM	Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire)
Mar-04-25 04:05PM	Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025 (GlobeNewswire)
04:00PM	Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:00AM	Absci to Participate in the KeyBanc Capital Markets Healthcare Forum (GlobeNewswire)
Mar-01-25 05:19PM	Why Absci Corporation (ABSI) is Skyrocketing So Far in 2025 (Insider Monkey)
Feb-18-25 08:00AM	Absci to Participate in the TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-12-25 09:24AM	Is Absci Corp. (ABSI) the Best Nasdaq Stock Under $5 to Buy? (Insider Monkey)
Feb-11-25 09:00AM	FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape (PR Newswire) +13.39%
Jan-24-25 11:54AM	Absci Corporation (ABSI): Pioneering AI-Driven Antibody Discovery with a Buy Rating from Needham (Insider Monkey)
Jan-22-25 01:22PM	Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside (Benzinga) +25.16%
08:00AM	Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference (GlobeNewswire)
Jan-17-25 05:58PM	Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028 (PR Newswire) +11.03%
01:54PM	Absci Corporation (ABSI): AI in Biopharma Discovery (Insider Monkey)
Jan-11-25 07:40AM	Absci, Owkin announce partnership to bring together AI platforms (TipRanks)
Jan-10-25 05:48PM	Advanced Micro Devices (AMD) Invests in Absci for AI-Driven Drug Discovery with High-Performance Computing Solutions (Insider Monkey) -11.34%
07:30AM	Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery (GlobeNewswire)
Jan-08-25 01:14PM	AMD Shares Slide as HSBC Downgrades Stock Over Nvidia Concerns; Absci Collaboration Announced (GuruFocus.com)
09:12AM	Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery (Benzinga)
07:00AM	Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery (GlobeNewswire)
06:32AM	AMD Invests in Drug-Discovery Company Absci in Push to Sell AI Chips (The Wall Street Journal)
Jan-06-25 08:00AM	Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health (GlobeNewswire)
Jan-02-25 08:00AM	Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-30-24 02:39PM	Why Absci Corporation (ABSI) Is One of the Best Biotech Penny Stocks to Invest in Now? (Insider Monkey)
Dec-13-24 08:10AM	Absci highlights progress, updates across proprietary pipeline (TipRanks)
Dec-12-24 08:00AM	Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 RandD Day (GlobeNewswire) -15.98%
08:00AM	Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day (GlobeNewswire)
Nov-21-24 08:00AM	Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-20-24 09:15AM	AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care (PR Newswire)
Nov-13-24 02:07AM	Absci Corp (ABSI) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial Challenges (GuruFocus.com) -13.74%
Nov-12-24 09:23PM	Q3 2024 Absci Corp Earnings Call (Thomson Reuters StreetEvents) -14.95%
08:50AM	Absci Corporation (ABSI) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results (GlobeNewswire)
Nov-11-24 07:15AM	Absci Corp (ABSI) Q3 2024 Earnings Report Preview: What to Look For (GuruFocus.com) +5.16%
Nov-07-24 08:00AM	Absci to Host R&D Day on December 12, 2024 (GlobeNewswire)
Oct-31-24 08:00AM	Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI (GlobeNewswire) -7.25%
Oct-24-24 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-15-24 08:00AM	Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024 (GlobeNewswire)
Aug-31-24 02:37PM	Absci Corporation (ABSI): A Penny Stock That Will Make You a Millionaire (Insider Monkey)
Aug-30-24 10:30AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Aug-21-24 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-14-24 05:30PM	Absci Corporation (ABSI) Reports Q2 Loss, Lags Revenue Estimates (Zacks) +10.99%
04:01PM	Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results (GlobeNewswire)
Aug-12-24 08:00AM	Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI (GlobeNewswire)
Jul-31-24 04:25AM	Why Is Absci Corporation (ABSI) Among the Best Micro Cap Stocks Right Now? (Insider Monkey)
Jul-10-24 08:00AM	Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024 (GlobeNewswire)
Jul-03-24 04:00PM	Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.07%
Jun-21-24 11:08AM	Is Absci Corporation (NASDAQ:ABSCI) the Best Halal Stock According to Hedge Funds? (Insider Monkey)
Jun-12-24 08:00AM	Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit (GlobeNewswire) +9.98%
May-28-24 08:00AM	Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
May-20-24 09:32PM	Cathie Wood Pulls the Trigger on These 2 Strong Buy Stocks (TipRanks)
May-16-24 07:15AM	7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs (InvestorPlace)
May-15-24 03:01AM	Absci Corp (ABSI) Q1 2024 Earnings Call Transcript Highlights: Strategic Advancements and ... (GuruFocus.com)
May-14-24 11:53AM	ABSI Stock Earnings: Absci Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:30AM	Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results (GlobeNewswire)
May-12-24 03:26PM	13 Penny Stocks with Insider Buying in 2024 (Insider Monkey)
May-07-24 09:13AM	Absci (ABSI) to Report Q1 Earnings: Here's What to Expect (Zacks)
Apr-16-24 08:00AM	Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024 (GlobeNewswire)
Apr-10-24 11:07AM	Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last? (Zacks) -7.67%
Mar-28-24 04:05PM	Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-23-24 05:31AM	Absci Corp (ABSI) Earnings: Misses Revenue Estimates and Reports Increased Net Loss (GuruFocus.com)
Mar-21-24 02:52PM	ABSI Stock Earnings: Absci Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
07:30AM	Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results (GlobeNewswire)
Mar-12-24 05:34PM	11 Stocks Insiders are Buying Now (Insider Monkey) +5.11%
Mar-06-24 06:34AM	Latest Updates of Viva Biotech's Portfolio Companies (PR Newswire)

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pangalos Menelas N	Director	Sep 22 '25	Buy	2.66	95,785	254,788	113,960	Sep 24 04:03 PM
Bedrick Todd	SVP, CAO	Sep 22 '25	Buy	2.70	10,000	27,000	180,428	Sep 24 04:03 PM
Busch Andreas	Chief Innovation Officer	Jul 28 '25	Buy	3.04	50,000	152,000	327,264	Jul 29 08:37 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABSI

Absci Corp

Upgrade your FINVIZ experience